VanEck Associates’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-59
Closed -$2K 1437
2023
Q4
$2K Hold
59
﹤0.01% 1386
2023
Q3
$2K Hold
59
﹤0.01% 1393
2023
Q2
$2K Hold
59
﹤0.01% 1398
2023
Q1
$2K Hold
59
﹤0.01% 1412
2022
Q4
$2K Hold
59
﹤0.01% 1416
2022
Q3
$2K Hold
59
﹤0.01% 1376
2022
Q2
$2K Hold
59
﹤0.01% 1363
2022
Q1
$3K Hold
59
﹤0.01% 1347
2021
Q4
$3K Buy
+59
New +$3.06K ﹤0.01% 1356

Other funds holding HEAL

VanEck Associates's HEAL Position: Q1 2024 in Review

VanEck Associates sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q1 2024, closing a stake of 59 shares — an estimated $2K sold.

VanEck Associates first reported a position in HEAL in Q4 2021 and held it in 9 quarters. The position peaked at $3K in Q1 2022. 38 funds tracked by Wall St. Rank hold HEAL as of Q1 2024.

  • VanEck Associates reported no remaining Global X Funds Global X HealthTech ETF position as of Q1 2024 after selling out during the quarter.
  • VanEck Associates sold 59 Global X Funds Global X HealthTech ETF shares in Q1 2024, an estimated $2K.
  • VanEck Associates first reported a position in Global X Funds Global X HealthTech ETF in Q4 2021 and held it in 9 quarters.
  • VanEck Associates's Global X Funds Global X HealthTech ETF position peaked at $3K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q1 2024.

Based on VanEck Associates's 13F filing for Q1 2024, filed 30 Apr 2024.